GDC-0575 dihydrochloride (Synonyms: ARRY-575 dihydrochloride; RG7741 dihydrochloride)
目录号: PL13950 纯度: ≥99%
CAS No. :1657014-42-0
商品编号 规格 价格 会员价 是否有货 数量
PL13950-5mg 5mg ¥2349.09 请登录
PL13950-10mg 10mg ¥3709.09 请登录
PL13950-25mg 25mg ¥6429.09 请登录
PL13950-50mg 50mg ¥9643.64 请登录
PL13950-100mg 100mg ¥14465.45 请登录
PL13950-200mg 200mg 询价 询价
PL13950-500mg 500mg 询价 询价
PL13950-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2584.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
GDC-0575 dihydrochloride
英文名称
GDC-0575 dihydrochloride
英文别名
GDC0575 dihydrochloride;(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide dihydrochloride;GDC-0575 dihydrochloride;ARRY-575 dihydrochloride;RG7741 dihydrochloride
Cas No.
1657014-42-0
分子式
C17H23BrCl2N4O
分子量
450.20
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) 是一种选择性的,可口服的 CHK1 抑制剂,IC50 值为 1.2 nM,具有抗肿瘤活性。
生物活性
GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) is an orally bioavailable CHK1 inhibitor, with an IC 50 of 1.2 nM, and has antitumor activity.
性状
Solid
IC50 & Target[1][2]
Chk1 1.2 nM (IC50)
体外研究(In Vitro)
GDC-0575 dihydrochloride is a selective and orally bioavailable CHK1 inhibitor, with an IC50 of 1.2 nM. GDC-0575 (100 nM) suppressses CHK1 activation induced by AraC by decreasing the level of Tyr15-phosphorylated CDK2. GDC-0575 (100 nM) has no effect on the viability of AML cells, but significantly reduces cell viability and induces apoptosis in combination with AraC. In addition, GDC-0575 plus AraC shows no effect on normal hematopoietic stem and progenitor cells (HSPCs). GDC-0575 shows cytotoxic activity against most of 20 melanoma cell lines tested, but several cell lines grown as tumour sphere (TS) are relatively insensitive. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
GDC-0575 (7.5 mg/kg, p.o.) in combination with AraC alomost completely eradicates leukemic burden in mice transplanted with U937-Luc cells, and shows more efficient activity than AraC alone. Furthermore, GDC-0575 elevates the cytotoxicity of AraC in different primary AML models in vivo. GDC-0575 (25, 50 mg/kg, p.o.) dose-dependently inhibits the growth of tumor in D20 and C002 xenografts. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Di Tullio A, et al. The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nat Commun. 2017 Nov 22;8(1):1679.
[2]. Oo ZY, et al. Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo. Clin Cancer Res. 2018 Jun 15;24(12):2901-2912.
溶解度数据
In Vitro: DMSO : 65 mg/mL (144.06 mM; Need ultrasonic)H2O : 25 mg/mL (55.41 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2